
News from european-biotechnology.com
Top European-biotechnology.com News

Eli Lilly · United StatesEli Lilly on Tuesday said its daily weight loss pill helped patients with obesity and Type 2 diabetes shed weight in a late-stage trial, meeting the study’s main goal and clearing the way for the company to file for approval of the drug globally. See the Story
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
70% Center coverage: 20 sources